AVITA Medical's top three insider shareholders as of March 23, 2026 are Michael S Perry (Director, 229.54K shares), David D O'Toole (Cfo, 141.93K shares), Nicole Kelsey (Chief Legal Officer, 98.39K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Michael S Perry | 229,543 | 0 | 22 Nov, 2022 | |
| David D O'Toole | Cfo | 141,927 | 0 | 11 Mar, 2026 |
| Nicole Kelsey | Chief Legal Officer | 98,390 | 0 | 19 Feb, 2026 |
| Robert Mcnamara | 86,771 | 0 | 29 Aug, 2025 | |
| Lou Panaccio | 56,428 | 0 | 05 Jun, 2025 | |
| Jan Stern Reed | 51,011 | 0 | 05 Jun, 2025 | |
| Suzanne Crowe | 46,934 | 0 | 05 Jun, 2025 | |
| Michael Holder | Chief Financial Officer | 46,450 | 0 | 06 Jul, 2022 |
| Andrew Quick | Chief Technology Officer | 46,450 | 0 | 06 Jul, 2022 |
| Erin Liberto | Chief Commercial Officer | 46,450 | 0 | 06 Jul, 2022 |
| Kathy M. Mcgee | Chief Operating Officer | 46,450 | 0 | 06 Jul, 2022 |
| Donna Shiroma | General Counsel | 45,951 | 0 | 03 Jun, 2024 |
| Jeremy Curnock Cook | 39,836 | 0 | 05 Jun, 2025 | |
| Cary Guy Vance | 35,771 | 0 | 05 Jun, 2025 | |
| James Corbett | Ceo | 11,580 | 0 | 27 Dec, 2023 |
| Louis Drapeau | 4,689 | 0 | 27 Dec, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Mar, 2026 | David D O'Toole | Common Stock | A | 1,800 | $4.78 | 141,927 | D | P |
| 19 Feb, 2026 | David D O'Toole | Common Stock | A | 3,000 | $4.15 | 140,127 | D | P |
| 18 Feb, 2026 | David D O'Toole | Common Stock | A | 105,470 | - | 137,127 | D | A |
| 18 Feb, 2026 | Nicole Kelsey | Common Stock | A | 98,390 | - | 98,390 | D | A |
| 18 Feb, 2026 | David D O'Toole | Stock Options (Right to Buy) | A | 155,510 | $0.00 | 155,510 | D | A |
| 18 Feb, 2026 | Nicole Kelsey | Stock Options (Right to Buy) | A | 145,060 | $0.00 | 145,060 | D | A |
| 28 Aug, 2025 | Robert Mcnamara | Common Stock | A | 10,000 | $4.50 | 86,771 | D | P |
| 26 Aug, 2025 | David D O'Toole | Common Stock | A | 2,000 | $4.52 | 31,657 | D | P |
| 19 Aug, 2025 | Robert Mcnamara | Common Stock | A | 10,000 | $5.00 | 76,771 | D | P |
| 12 Aug, 2025 | David D O'Toole | Common Stock | A | 2,000 | $4.81 | 29,657 | D | P |
| 21 Jan, 2025 | Jeremy Curnock Cook | Common Stock | A | 10,022 | - | 39,836 | D | A |
| 21 Jan, 2025 | Jan Stern Reed | Common Stock | A | 10,022 | - | 51,011 | D | A |
| 21 Jan, 2025 | Cary Guy Vance | Common Stock | A | 10,022 | - | 35,771 | D | A |
| 21 Jan, 2025 | James Corbett | Stock Options (Right to Buy) | A | 520,000 | $0.00 | 520,000 | D | A |
| 21 Jan, 2025 | Lou Panaccio | Common Stock | A | 10,022 | - | 56,428 | D | A |
| 21 Jan, 2025 | Suzanne Crowe | Common Stock | A | 10,022 | - | 46,934 | D | A |
| 21 Jan, 2025 | Robert Mcnamara | Common Stock | A | 10,022 | - | 66,771 | D | A |
| 21 Jan, 2025 | Jan Stern Reed | Stock Options (Right to Buy) | A | 4,295 | $0.00 | 4,295 | D | A |
| 21 Jan, 2025 | Robert Mcnamara | Stock Options (Right to Buy) | A | 4,295 | $0.00 | 4,295 | D | A |
| 21 Jan, 2025 | Cary Guy Vance | Stock Options (Right to Buy) | A | 4,295 | $0.00 | 4,295 | D | A |